Data indicates rising adoption of technology in Canadian clinical trials

December 18, 2009

OTTAWA - A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41%) have moved away from collecting and managing trial data using only paper records.

In his study titled "The Use of Electronic Data Capture Tools in Clinical Trials: Web-survey of 259 Canadian Trials" published in the Journal of Medical Internet Research, Dr. El Emam and his team found that during the 2006 and 2007 calendar years, there were approximately 950 clinical trials registered with sites in Canada. About half of these were funded by the pharmaceutical industry. Industry trials tend to be 3 to 4 times larger, on average, than academic trials. Less than 10% of Canadian trials target a pediatric population, which also tend to be significantly smaller than those targeting adult populations. Industry funded trials were more likely to be using electronic data capture (EDC) tools. There was no difference between pediatric and adult trials in terms of the use of EDC, but pediatric trials were using more sophisticated EDC systems.

Electronic data capture tools allow researchers to complete a trial in less time and with fewer errors than if they were using the old paper method to capture and process data manually before entering it into a computer.

"The adoption of technology to collect and manage data in clinical trials is increasing, but mostly for industry funded trials. Should academic trials continue to move in that direction, they are expected to gain efficiency and quality benefits." explained Dr. El Emam.

Children's Hospital of Eastern Ontario Research Institute

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to